As of Sep 23
| -0.19 / -1.01%|
The 6 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 23.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +23.46% increase from the last price of 18.63.
The current consensus among 7 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.